BioAtla (BCAB) Enterprise Value (2020 - 2026)

BioAtla's Enterprise Value history runs 7 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 93.94% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$2.0 million, a 93.94% increase from a year earlier, with the FY2025 full-year figure at -$7.1 million, up 85.49% from the prior year.
• Enterprise Value rose to -$2.0 million in Q1 2026 per BCAB's latest filing, from -$7.1 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$2.0 million in Q1 2026 and bottomed at -$219.4 million in Q1 2022.
• The 5-year median for Enterprise Value is -$71.1 million (2024), against an average of -$95.6 million.
• Across the five-year window, Enterprise Value increased 0.8% in 2022 and surged 93.94% in 2026, its largest moves.
• Year by year, Enterprise Value stood at -$178.1 million in 2022, then surged by 37.42% to -$111.5 million in 2023, then soared by 56.0% to -$49.0 million in 2024, then surged by 85.49% to -$7.1 million in 2025, then surged by 72.45% to -$2.0 million in 2026.
• Per Business Quant, the three latest BCAB Enterprise Value figures stand at -$2.0 million (Q1 2026), -$7.1 million (Q4 2025), and -$8.3 million (Q3 2025).